The global Oral Anti-allergic Drugs market was valued at 27110 million in 2024 and is projected to reach US$ 35720 million by 2031, at a CAGR of 4.1% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral Anti-allergic Drugs manufacturers, suppliers, distributors, and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for Oral Anti-allergic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Anti-allergic Drugs. This report contains market size and forecasts of Oral Anti-allergic Drugs in global, including the following market information:
Global Oral Anti-allergic Drugs market revenue, 2020-2025, 2026-2031, ($ millions)
Global Oral Anti-allergic Drugs market sales, 2020-2025, 2026-2031, (K Units)
Global top five Oral Anti-allergic Drugs companies in 2024 (%)
Total Market by Segment:
Global Oral Anti-allergic Drugs market, by Type, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Oral Anti-allergic Drugs market segment percentages, by Type, 2024 (%)
Antihistamine Drugs
Allergic Mediator Release Agent
Immunosuppressant Drugs
Global Oral Anti-allergic Drugs market, by Application, 2020-2025, 2026-2031 ($ Millions) & (K Units)
Global Oral Anti-allergic Drugs market segment percentages, by Application, 2024 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Oral Anti-allergic Drugs market, by region and country, 2020-2025, 2026-2031 ($ millions) & (K Units)
Global Oral Anti-allergic Drugs market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral Anti-allergic Drugs revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies Oral Anti-allergic Drugs revenues share in global market, 2024 (%)
Key companies Oral Anti-allergic Drugs sales in global market, 2020-2025 (estimated), (K Units)
Key companies Oral Anti-allergic Drugs sales share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Johnson & Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Almirall
Pfizer
AstraZeneca
Sun Pharma
Novartis
Boehringer Ingelheim
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral Anti-allergic Drugs, market overview.
Chapter 2: Global Oral Anti-allergic Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Oral Anti-allergic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral Anti-allergic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral Anti-allergic Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Oral Anti-allergic Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global Oral Anti-allergic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral Anti-allergic Drugs Overall Market Size
2.1 Global Oral Anti-allergic Drugs Market Size: 2024 VS 2031
2.2 Global Oral Anti-allergic Drugs Market Size, Prospects & Forecasts: 2020-2031
2.3 Global Oral Anti-allergic Drugs Sales: 2020-2031
3 Company Landscape
3.1 Top Oral Anti-allergic Drugs Players in Global Market
3.2 Top Global Oral Anti-allergic Drugs Companies Ranked by Revenue
3.3 Global Oral Anti-allergic Drugs Revenue by Companies
3.4 Global Oral Anti-allergic Drugs Sales by Companies
3.5 Global Oral Anti-allergic Drugs Price by Manufacturer (2020-2025)
3.6 Top 3 and Top 5 Oral Anti-allergic Drugs Companies in Global Market, by Revenue in 2024
3.7 Global Manufacturers Oral Anti-allergic Drugs Product Type
3.8 Tier 1, Tier 2, and Tier 3 Oral Anti-allergic Drugs Players in Global Market
3.8.1 List of Global Tier 1 Oral Anti-allergic Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral Anti-allergic Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 Segment by Type - Global Oral Anti-allergic Drugs Market Size Markets, 2024 & 2031
4.1.2 Antihistamine Drugs
4.1.3 Allergic Mediator Release Agent
4.1.4 Immunosuppressant Drugs
4.2 Segment by Type - Global Oral Anti-allergic Drugs Revenue & Forecasts
4.2.1 Segment by Type - Global Oral Anti-allergic Drugs Revenue, 2020-2025
4.2.2 Segment by Type - Global Oral Anti-allergic Drugs Revenue, 2026-2031
4.2.3 Segment by Type - Global Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
4.3 Segment by Type - Global Oral Anti-allergic Drugs Sales & Forecasts
4.3.1 Segment by Type - Global Oral Anti-allergic Drugs Sales, 2020-2025
4.3.2 Segment by Type - Global Oral Anti-allergic Drugs Sales, 2026-2031
4.3.3 Segment by Type - Global Oral Anti-allergic Drugs Sales Market Share, 2020-2031
4.4 Segment by Type - Global Oral Anti-allergic Drugs Price (Manufacturers Selling Prices), 2020-2031
5 Sights by Application
5.1 Overview
5.1.1 Segment by Application - Global Oral Anti-allergic Drugs Market Size, 2024 & 2031
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 Segment by Application - Global Oral Anti-allergic Drugs Revenue & Forecasts
5.2.1 Segment by Application - Global Oral Anti-allergic Drugs Revenue, 2020-2025
5.2.2 Segment by Application - Global Oral Anti-allergic Drugs Revenue, 2026-2031
5.2.3 Segment by Application - Global Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
5.3 Segment by Application - Global Oral Anti-allergic Drugs Sales & Forecasts
5.3.1 Segment by Application - Global Oral Anti-allergic Drugs Sales, 2020-2025
5.3.2 Segment by Application - Global Oral Anti-allergic Drugs Sales, 2026-2031
5.3.3 Segment by Application - Global Oral Anti-allergic Drugs Sales Market Share, 2020-2031
5.4 Segment by Application - Global Oral Anti-allergic Drugs Price (Manufacturers Selling Prices), 2020-2031
6 Sights by Region
6.1 By Region - Global Oral Anti-allergic Drugs Market Size, 2024 & 2031
6.2 By Region - Global Oral Anti-allergic Drugs Revenue & Forecasts
6.2.1 By Region - Global Oral Anti-allergic Drugs Revenue, 2020-2025
6.2.2 By Region - Global Oral Anti-allergic Drugs Revenue, 2026-2031
6.2.3 By Region - Global Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
6.3 By Region - Global Oral Anti-allergic Drugs Sales & Forecasts
6.3.1 By Region - Global Oral Anti-allergic Drugs Sales, 2020-2025
6.3.2 By Region - Global Oral Anti-allergic Drugs Sales, 2026-2031
6.3.3 By Region - Global Oral Anti-allergic Drugs Sales Market Share, 2020-2031
6.4 North America
6.4.1 By Country - North America Oral Anti-allergic Drugs Revenue, 2020-2031
6.4.2 By Country - North America Oral Anti-allergic Drugs Sales, 2020-2031
6.4.3 United States Oral Anti-allergic Drugs Market Size, 2020-2031
6.4.4 Canada Oral Anti-allergic Drugs Market Size, 2020-2031
6.4.5 Mexico Oral Anti-allergic Drugs Market Size, 2020-2031
6.5 Europe
6.5.1 By Country - Europe Oral Anti-allergic Drugs Revenue, 2020-2031
6.5.2 By Country - Europe Oral Anti-allergic Drugs Sales, 2020-2031
6.5.3 Germany Oral Anti-allergic Drugs Market Size, 2020-2031
6.5.4 France Oral Anti-allergic Drugs Market Size, 2020-2031
6.5.5 U.K. Oral Anti-allergic Drugs Market Size, 2020-2031
6.5.6 Italy Oral Anti-allergic Drugs Market Size, 2020-2031
6.5.7 Russia Oral Anti-allergic Drugs Market Size, 2020-2031
6.5.8 Nordic Countries Oral Anti-allergic Drugs Market Size, 2020-2031
6.5.9 Benelux Oral Anti-allergic Drugs Market Size, 2020-2031
6.6 Asia
6.6.1 By Region - Asia Oral Anti-allergic Drugs Revenue, 2020-2031
6.6.2 By Region - Asia Oral Anti-allergic Drugs Sales, 2020-2031
6.6.3 China Oral Anti-allergic Drugs Market Size, 2020-2031
6.6.4 Japan Oral Anti-allergic Drugs Market Size, 2020-2031
6.6.5 South Korea Oral Anti-allergic Drugs Market Size, 2020-2031
6.6.6 Southeast Asia Oral Anti-allergic Drugs Market Size, 2020-2031
6.6.7 India Oral Anti-allergic Drugs Market Size, 2020-2031
6.7 South America
6.7.1 By Country - South America Oral Anti-allergic Drugs Revenue, 2020-2031
6.7.2 By Country - South America Oral Anti-allergic Drugs Sales, 2020-2031
6.7.3 Brazil Oral Anti-allergic Drugs Market Size, 2020-2031
6.7.4 Argentina Oral Anti-allergic Drugs Market Size, 2020-2031
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Oral Anti-allergic Drugs Revenue, 2020-2031
6.8.2 By Country - Middle East & Africa Oral Anti-allergic Drugs Sales, 2020-2031
6.8.3 Turkey Oral Anti-allergic Drugs Market Size, 2020-2031
6.8.4 Israel Oral Anti-allergic Drugs Market Size, 2020-2031
6.8.5 Saudi Arabia Oral Anti-allergic Drugs Market Size, 2020-2031
6.8.6 UAE Oral Anti-allergic Drugs Market Size, 2020-2031
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Oral Anti-allergic Drugs Major Product Offerings
7.1.4 Sanofi Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.1.5 Sanofi Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Oral Anti-allergic Drugs Major Product Offerings
7.2.4 Johnson & Johnson Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Oral Anti-allergic Drugs Major Product Offerings
7.3.4 Merck Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.3.5 Merck Key News & Latest Developments
7.4 Teva
7.4.1 Teva Company Summary
7.4.2 Teva Business Overview
7.4.3 Teva Oral Anti-allergic Drugs Major Product Offerings
7.4.4 Teva Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.4.5 Teva Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Oral Anti-allergic Drugs Major Product Offerings
7.5.4 GlaxoSmithKline Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Bayer
7.6.1 Bayer Company Summary
7.6.2 Bayer Business Overview
7.6.3 Bayer Oral Anti-allergic Drugs Major Product Offerings
7.6.4 Bayer Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.6.5 Bayer Key News & Latest Developments
7.7 Almirall
7.7.1 Almirall Company Summary
7.7.2 Almirall Business Overview
7.7.3 Almirall Oral Anti-allergic Drugs Major Product Offerings
7.7.4 Almirall Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.7.5 Almirall Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Oral Anti-allergic Drugs Major Product Offerings
7.8.4 Pfizer Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.8.5 Pfizer Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Oral Anti-allergic Drugs Major Product Offerings
7.9.4 AstraZeneca Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Sun Pharma
7.10.1 Sun Pharma Company Summary
7.10.2 Sun Pharma Business Overview
7.10.3 Sun Pharma Oral Anti-allergic Drugs Major Product Offerings
7.10.4 Sun Pharma Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.10.5 Sun Pharma Key News & Latest Developments
7.11 Novartis
7.11.1 Novartis Company Summary
7.11.2 Novartis Business Overview
7.11.3 Novartis Oral Anti-allergic Drugs Major Product Offerings
7.11.4 Novartis Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.11.5 Novartis Key News & Latest Developments
7.12 Boehringer Ingelheim
7.12.1 Boehringer Ingelheim Company Summary
7.12.2 Boehringer Ingelheim Business Overview
7.12.3 Boehringer Ingelheim Oral Anti-allergic Drugs Major Product Offerings
7.12.4 Boehringer Ingelheim Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.12.5 Boehringer Ingelheim Key News & Latest Developments
7.13 UCB Pharma
7.13.1 UCB Pharma Company Summary
7.13.2 UCB Pharma Business Overview
7.13.3 UCB Pharma Oral Anti-allergic Drugs Major Product Offerings
7.13.4 UCB Pharma Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.13.5 UCB Pharma Key News & Latest Developments
7.14 Yangtze River Pharmaceutical Group
7.14.1 Yangtze River Pharmaceutical Group Company Summary
7.14.2 Yangtze River Pharmaceutical Group Business Overview
7.14.3 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Major Product Offerings
7.14.4 Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.14.5 Yangtze River Pharmaceutical Group Key News & Latest Developments
7.15 Hainan Poly Pharm
7.15.1 Hainan Poly Pharm Company Summary
7.15.2 Hainan Poly Pharm Business Overview
7.15.3 Hainan Poly Pharm Oral Anti-allergic Drugs Major Product Offerings
7.15.4 Hainan Poly Pharm Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.15.5 Hainan Poly Pharm Key News & Latest Developments
7.16 Chongqing Huapont Pharmaceutical
7.16.1 Chongqing Huapont Pharmaceutical Company Summary
7.16.2 Chongqing Huapont Pharmaceutical Business Overview
7.16.3 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Major Product Offerings
7.16.4 Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.16.5 Chongqing Huapont Pharmaceutical Key News & Latest Developments
7.17 Dawnrays Pharma
7.17.1 Dawnrays Pharma Company Summary
7.17.2 Dawnrays Pharma Business Overview
7.17.3 Dawnrays Pharma Oral Anti-allergic Drugs Major Product Offerings
7.17.4 Dawnrays Pharma Oral Anti-allergic Drugs Sales and Revenue in Global (2020-2025)
7.17.5 Dawnrays Pharma Key News & Latest Developments
8 Global Oral Anti-allergic Drugs Production Capacity, Analysis
8.1 Global Oral Anti-allergic Drugs Production Capacity, 2020-2031
8.2 Oral Anti-allergic Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral Anti-allergic Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral Anti-allergic Drugs Supply Chain Analysis
10.1 Oral Anti-allergic Drugs Industry Value Chain
10.2 Oral Anti-allergic Drugs Upstream Market
10.3 Oral Anti-allergic Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral Anti-allergic Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Oral Anti-allergic Drugs in Global Market
Table 2. Top Oral Anti-allergic Drugs Players in Global Market, Ranking by Revenue (2024)
Table 3. Global Oral Anti-allergic Drugs Revenue by Companies, (US$, Mn), 2020-2025
Table 4. Global Oral Anti-allergic Drugs Revenue Share by Companies, 2020-2025
Table 5. Global Oral Anti-allergic Drugs Sales by Companies, (K Units), 2020-2025
Table 6. Global Oral Anti-allergic Drugs Sales Share by Companies, 2020-2025
Table 7. Key Manufacturers Oral Anti-allergic Drugs Price (2020-2025) & (US$/Unit)
Table 8. Global Manufacturers Oral Anti-allergic Drugs Product Type
Table 9. List of Global Tier 1 Oral Anti-allergic Drugs Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oral Anti-allergic Drugs Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segment by Type – Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2024 & 2031
Table 12. Segment by Type - Global Oral Anti-allergic Drugs Revenue (US$, Mn), 2020-2025
Table 13. Segment by Type - Global Oral Anti-allergic Drugs Revenue (US$, Mn), 2026-2031
Table 14. Segment by Type - Global Oral Anti-allergic Drugs Sales (K Units), 2020-2025
Table 15. Segment by Type - Global Oral Anti-allergic Drugs Sales (K Units), 2026-2031
Table 16. Segment by Application – Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2024 & 2031
Table 17. Segment by Application - Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2025
Table 18. Segment by Application - Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2026-2031
Table 19. Segment by Application - Global Oral Anti-allergic Drugs Sales, (K Units), 2020-2025
Table 20. Segment by Application - Global Oral Anti-allergic Drugs Sales, (K Units), 2026-2031
Table 21. By Region – Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2025-2031
Table 22. By Region - Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2025
Table 23. By Region - Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2026-2031
Table 24. By Region - Global Oral Anti-allergic Drugs Sales, (K Units), 2020-2025
Table 25. By Region - Global Oral Anti-allergic Drugs Sales, (K Units), 2026-2031
Table 26. By Country - North America Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2025
Table 27. By Country - North America Oral Anti-allergic Drugs Revenue, (US$, Mn), 2026-2031
Table 28. By Country - North America Oral Anti-allergic Drugs Sales, (K Units), 2020-2025
Table 29. By Country - North America Oral Anti-allergic Drugs Sales, (K Units), 2026-2031
Table 30. By Country - Europe Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2025
Table 31. By Country - Europe Oral Anti-allergic Drugs Revenue, (US$, Mn), 2026-2031
Table 32. By Country - Europe Oral Anti-allergic Drugs Sales, (K Units), 2020-2025
Table 33. By Country - Europe Oral Anti-allergic Drugs Sales, (K Units), 2026-2031
Table 34. By Region - Asia Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2025
Table 35. By Region - Asia Oral Anti-allergic Drugs Revenue, (US$, Mn), 2026-2031
Table 36. By Region - Asia Oral Anti-allergic Drugs Sales, (K Units), 2020-2025
Table 37. By Region - Asia Oral Anti-allergic Drugs Sales, (K Units), 2026-2031
Table 38. By Country - South America Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2025
Table 39. By Country - South America Oral Anti-allergic Drugs Revenue, (US$, Mn), 2026-2031
Table 40. By Country - South America Oral Anti-allergic Drugs Sales, (K Units), 2020-2025
Table 41. By Country - South America Oral Anti-allergic Drugs Sales, (K Units), 2026-2031
Table 42. By Country - Middle East & Africa Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2025
Table 43. By Country - Middle East & Africa Oral Anti-allergic Drugs Revenue, (US$, Mn), 2026-2031
Table 44. By Country - Middle East & Africa Oral Anti-allergic Drugs Sales, (K Units), 2020-2025
Table 45. By Country - Middle East & Africa Oral Anti-allergic Drugs Sales, (K Units), 2026-2031
Table 46. Sanofi Company Summary
Table 47. Sanofi Oral Anti-allergic Drugs Product Offerings
Table 48. Sanofi Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 49. Sanofi Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Oral Anti-allergic Drugs Product Offerings
Table 52. Johnson & Johnson Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Merck Company Summary
Table 55. Merck Oral Anti-allergic Drugs Product Offerings
Table 56. Merck Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 57. Merck Key News & Latest Developments
Table 58. Teva Company Summary
Table 59. Teva Oral Anti-allergic Drugs Product Offerings
Table 60. Teva Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 61. Teva Key News & Latest Developments
Table 62. GlaxoSmithKline Company Summary
Table 63. GlaxoSmithKline Oral Anti-allergic Drugs Product Offerings
Table 64. GlaxoSmithKline Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 65. GlaxoSmithKline Key News & Latest Developments
Table 66. Bayer Company Summary
Table 67. Bayer Oral Anti-allergic Drugs Product Offerings
Table 68. Bayer Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 69. Bayer Key News & Latest Developments
Table 70. Almirall Company Summary
Table 71. Almirall Oral Anti-allergic Drugs Product Offerings
Table 72. Almirall Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 73. Almirall Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Oral Anti-allergic Drugs Product Offerings
Table 76. Pfizer Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 77. Pfizer Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca Oral Anti-allergic Drugs Product Offerings
Table 80. AstraZeneca Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 81. AstraZeneca Key News & Latest Developments
Table 82. Sun Pharma Company Summary
Table 83. Sun Pharma Oral Anti-allergic Drugs Product Offerings
Table 84. Sun Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 85. Sun Pharma Key News & Latest Developments
Table 86. Novartis Company Summary
Table 87. Novartis Oral Anti-allergic Drugs Product Offerings
Table 88. Novartis Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 89. Novartis Key News & Latest Developments
Table 90. Boehringer Ingelheim Company Summary
Table 91. Boehringer Ingelheim Oral Anti-allergic Drugs Product Offerings
Table 92. Boehringer Ingelheim Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 93. Boehringer Ingelheim Key News & Latest Developments
Table 94. UCB Pharma Company Summary
Table 95. UCB Pharma Oral Anti-allergic Drugs Product Offerings
Table 96. UCB Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 97. UCB Pharma Key News & Latest Developments
Table 98. Yangtze River Pharmaceutical Group Company Summary
Table 99. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Product Offerings
Table 100. Yangtze River Pharmaceutical Group Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 101. Yangtze River Pharmaceutical Group Key News & Latest Developments
Table 102. Hainan Poly Pharm Company Summary
Table 103. Hainan Poly Pharm Oral Anti-allergic Drugs Product Offerings
Table 104. Hainan Poly Pharm Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 105. Hainan Poly Pharm Key News & Latest Developments
Table 106. Chongqing Huapont Pharmaceutical Company Summary
Table 107. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Product Offerings
Table 108. Chongqing Huapont Pharmaceutical Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 109. Chongqing Huapont Pharmaceutical Key News & Latest Developments
Table 110. Dawnrays Pharma Company Summary
Table 111. Dawnrays Pharma Oral Anti-allergic Drugs Product Offerings
Table 112. Dawnrays Pharma Oral Anti-allergic Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) & (2020-2025)
Table 113. Dawnrays Pharma Key News & Latest Developments
Table 114. Oral Anti-allergic Drugs Capacity of Key Manufacturers in Global Market, 2023-2025 (K Units)
Table 115. Global Oral Anti-allergic Drugs Capacity Market Share of Key Manufacturers, 2023-2025
Table 116. Global Oral Anti-allergic Drugs Production by Region, 2020-2025 (K Units)
Table 117. Global Oral Anti-allergic Drugs Production by Region, 2026-2031 (K Units)
Table 118. Oral Anti-allergic Drugs Market Opportunities & Trends in Global Market
Table 119. Oral Anti-allergic Drugs Market Drivers in Global Market
Table 120. Oral Anti-allergic Drugs Market Restraints in Global Market
Table 121. Oral Anti-allergic Drugs Raw Materials
Table 122. Oral Anti-allergic Drugs Raw Materials Suppliers in Global Market
Table 123. Typical Oral Anti-allergic Drugs Downstream
Table 124. Oral Anti-allergic Drugs Downstream Clients in Global Market
Table 125. Oral Anti-allergic Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oral Anti-allergic Drugs Product Picture
Figure 2. Oral Anti-allergic Drugs Segment by Type in 2024
Figure 3. Oral Anti-allergic Drugs Segment by Application in 2024
Figure 4. Global Oral Anti-allergic Drugs Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global Oral Anti-allergic Drugs Market Size: 2024 VS 2031 (US$, Mn)
Figure 7. Global Oral Anti-allergic Drugs Revenue: 2020-2031 (US$, Mn)
Figure 8. Oral Anti-allergic Drugs Sales in Global Market: 2020-2031 (K Units)
Figure 9. The Top 3 and 5 Players Market Share by Oral Anti-allergic Drugs Revenue in 2024
Figure 10. Segment by Type – Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2024 & 2031
Figure 11. Segment by Type - Global Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
Figure 12. Segment by Type - Global Oral Anti-allergic Drugs Sales Market Share, 2020-2031
Figure 13. Segment by Type - Global Oral Anti-allergic Drugs Price (US$/Unit), 2020-2031
Figure 14. Segment by Application – Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2024 & 2031
Figure 15. Segment by Application - Global Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
Figure 16. Segment by Application - Global Oral Anti-allergic Drugs Sales Market Share, 2020-2031
Figure 17. Segment by Application -Global Oral Anti-allergic Drugs Price (US$/Unit), 2020-2031
Figure 18. By Region – Global Oral Anti-allergic Drugs Revenue, (US$, Mn), 2025 & 2031
Figure 19. By Region - Global Oral Anti-allergic Drugs Revenue Market Share, 2020 VS 2024 VS 2031
Figure 20. By Region - Global Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
Figure 21. By Region - Global Oral Anti-allergic Drugs Sales Market Share, 2020-2031
Figure 22. By Country - North America Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
Figure 23. By Country - North America Oral Anti-allergic Drugs Sales Market Share, 2020-2031
Figure 24. United States Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 25. Canada Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 26. Mexico Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 27. By Country - Europe Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
Figure 28. By Country - Europe Oral Anti-allergic Drugs Sales Market Share, 2020-2031
Figure 29. Germany Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 30. France Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 31. U.K. Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 32. Italy Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 33. Russia Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 34. Nordic Countries Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 35. Benelux Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 36. By Region - Asia Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
Figure 37. By Region - Asia Oral Anti-allergic Drugs Sales Market Share, 2020-2031
Figure 38. China Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 39. Japan Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 40. South Korea Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 41. Southeast Asia Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 42. India Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 43. By Country - South America Oral Anti-allergic Drugs Revenue Market Share, 2020-2031
Figure 44. By Country - South America Oral Anti-allergic Drugs Sales, Market Share, 2020-2031
Figure 45. Brazil Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 46. Argentina Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 47. By Country - Middle East & Africa Oral Anti-allergic Drugs Revenue, Market Share, 2020-2031
Figure 48. By Country - Middle East & Africa Oral Anti-allergic Drugs Sales, Market Share, 2020-2031
Figure 49. Turkey Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 50. Israel Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 51. Saudi Arabia Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 52. UAE Oral Anti-allergic Drugs Revenue, (US$, Mn), 2020-2031
Figure 53. Global Oral Anti-allergic Drugs Production Capacity (K Units), 2020-2031
Figure 54. The Percentage of Production Oral Anti-allergic Drugs by Region, 2024 VS 2031
Figure 55. Oral Anti-allergic Drugs Industry Value Chain
Figure 56. Marketing Channels
